Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.

Matthews, A; Langan, SM; Douglas, IJ; Smeeth, L; Bhaskaran, K; (2016) Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. PLoS medicine, 13 (6). e1002037. ISSN 1549-1277 DOI: https://doi.org/10.1371/journal.pmed.1002037

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pmed.1002037

Abstract

Share

Download

Filename: journal.pmed.1002037.PDF

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar